Neutralization of CD95 activity blocks invasion of glioblastoma cells in vivo

Details for Australian Patent Application No. 2007341631 (hide)

Owner Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Universitatsklinikum Heidelberg

Inventors Martin-Villalba, Ana; Krammer, Peter G.; Kleber, Susanne; Herold-Mende, Christel; Wiestler, Benedikt; Sancho-Martinez, Ignacio

Agent Davies Collison Cave

Pub. Number AU-B-2007341631

PCT Pub. Number WO2008/080623

Priority 60/877,367 28.12.06 US

Filing date 28 December 2007

Wipo publication date 10 July 2008

Acceptance publication date 30 August 2012

International Classifications

A61P 35/00 Antineoplastic agents

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/080623 Priority application(s): WO2008/080623

30 August 2012 Application Accepted

  Published as AU-B-2007341631

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007341647-Agents for controlling parasites on animals

2007341626-Method and device for treating a liquid